In the present article, when oncogene driver inhibitors were used in NSCLC cells silenced for ATM, we observed downregulation of OXPHOS indicating that ATM levels and its phosphorylation status are key factors for OXPHOS regulation. The gene discussed is ATM; the disease is non-small cell lung carcinoma.